ALEXION PHARMACEUTICALS, INC. - FORM 10-K - EX-23.1 - CONSENT OF PRICEWATERHOUSECOOPERS LLP - February 6, 2015

Attached files

file filename
EX-21.1 - SUBSIDIARIES OF ALEXION PHARMACEUTICALS, INC. - ALEXION PHARMACEUTICALS, INC.alxnex21112312014.htm
EX-10.28 - FIRST AMENDMENT TO CREDIT AGREEMENT - ALEXION PHARMACEUTICALS, INC.alxnex102812312014.htm
EX-10.16 - MASTER MANUFACTURING AND SUPPLY AGREEMENT - ALEXION PHARMACEUTICALS, INC.alxnex101612312014.htm
EX-10.29 - CONSENT AND SECOND AMENDMENT TO CREDIT AGREEMENT - ALEXION PHARMACEUTICALS, INC.alxnex102912312014.htm
EXCEL - IDEA: XBRL DOCUMENT - ALEXION PHARMACEUTICALS, INC.Financial_Report.xls
EX-32.2 - CERTIFICATION OF CFO PURSUANT TO SECTION 906 - ALEXION PHARMACEUTICALS, INC.alxnex32212312014.htm
EX-31.1 - CERTIFICATION OF CEO PURSUANT TO SECTION 302 - ALEXION PHARMACEUTICALS, INC.alxnex31112312014.htm
EX-32.1 - CERTIFICATION OF CEO PURSUANT TO SECTION 906 - ALEXION PHARMACEUTICALS, INC.alxnex32112312014.htm
10-K - FORM 10-K - ALEXION PHARMACEUTICALS, INC.alxn10k12312014.htm
EX-31.2 - CERTIFICATION OF CFO PURSUANT TO SECTION 302 - ALEXION PHARMACEUTICALS, INC.alxnex31212312014.htm


Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statement on Form S‑3 (No. 333-181595, 333-128085, 333-127471, 333-123828, 333-91265, 333-29617, 333-41397, 333-47645, 333-89343, 333-36738, 333-52886, 333-114449, 333-110828, 333-47954, and 333-59702) and Form S-8 (No. 333-146319, 333-139600, 333-123212, 333-119749, 333-24863, 333-52856, 333-69478, 333-71879, 333-71985, 333-106854 and 333-153612) of Alexion Pharmaceuticals, Inc. of our report dated February 6, 2015 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10‑K.

/s/ PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP
Hartford, Connecticut
February 6, 2015



ALEXION PHARMACEUTICALS, INC. Reports